Caspase-2 regulates oncogene-induced senescence

Oncotarget. 2014 Jul 30;5(14):5845-7. doi: 10.18632/oncotarget.2286.

Abstract

Cellular senescence is activated by numerous cellular insults, in particular those driving cancer formation, resulting in stable proliferation arrest and acquisition of specific features. By self-opposing to oncogenic stimulation, senescence is considered as a failsafe program, allowing, when functional, to inhibit cancers occurrence. Compelling evidences suggest a tumor suppressive activity of caspase-2, eventually independently of its effect on cell death. The original results described here demonstrate that this tumor suppressive activity of caspase-2 is mediated, at least in part, by its pro-senescing activity. Indeed, we have demonstrated in vitro and in vivo that loss of function of caspase-2 allows to escape oncogenic stress induced senescence. These results are discussed in the context of known tumor suppressive activity of caspase-2.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Caspase 2 / genetics*
  • Caspase 2 / metabolism
  • Cellular Senescence / genetics
  • Cysteine Endopeptidases / genetics*
  • Cysteine Endopeptidases / metabolism
  • DNA Damage
  • Humans
  • Mammary Glands, Human / enzymology*
  • Oncogenes
  • RNA, Small Interfering / administration & dosage
  • RNA, Small Interfering / genetics

Substances

  • RNA, Small Interfering
  • CASP2 protein, human
  • Caspase 2
  • Cysteine Endopeptidases